FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy, and can be used for increasing clinical effectiveness in postmenopausal osteoporosis. That is ensured by administering Bivalos (strontium ranelatum), one sachet a day at bedtime. Alpha-D3 1.0 mcg is prescribed once a day at bedtime for six months.
EFFECT: method provides higher clinical effectiveness and eliminated adverse side effects, and also considerably reduced risk of developing bone fractures, risk of falling due to improved coordination of movements and reduced muscle tone and pain syndrome intensity, expanded daily activity, self-service and routine homework abilities, enhanced possibility of independent movement, improved coordination of movements.
2 ex, 1 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING POSTMENOPAUSAL OSTEPOROSIS | 2009 |
|
RU2424815C2 |
| METHOD FOR STUDY OF BLOOD SERUM FOR PHARMACOLOGICAL CORRECTION IN OSTEOPOROSIS | 2004 |
|
RU2271007C2 |
| METHOD OF TREATING OSTEOPENIC SYNDROME IN POSTMENOPAUSAL OBESITY WOMEN | 2017 |
|
RU2698269C2 |
| METHOD OF TREATMENT OF OSTEOPOROSIS IN WOMEN IN POSTMENOPAUSE AGAINST THE BACKGROUND OF OBESITY | 2017 |
|
RU2657789C1 |
| METHOD FOR PREDICTION OF OSTEOPOROTIC SPINAL FRACTURES IN FEMALES AGED 50 AND OLDER | 2011 |
|
RU2465832C1 |
| METHOD FOR PHARMACOLOGICAL CORRECTION OF CALCIUM DEFICIENCY IN PATIENTS WITH OSTEOPOROSIS | 2003 |
|
RU2246303C2 |
| METHOD FOR PREDICTING THE PRESENCE OF OSTEOPOROSIS BY THE LEVEL OF ARTERIAL STIFFNESS AMONG PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR COMPLICATIONS | 2020 |
|
RU2746837C1 |
| METHOD FOR DETERMINING OPTIMAL INTERVAL BETWEEN OPERATIONS OF ENDOPROSTHESIS DURING BILATERAL HONARTHROSE OR COXARTHROSIS IN PATIENTS WITH OSTEOPOROSIS | 2016 |
|
RU2632705C1 |
| METHOD FOR CHOOSING THERAPEUTIC APPROACH TO OSTEOPENIA | 2009 |
|
RU2403859C1 |
| METHOD OF TREATING OSTEOARTHROSIS | 2009 |
|
RU2407507C1 |
